Oracle News - January 29, 2026
Oracle Stock Declines Amid Analyst Downgrade and AI Cost Concerns
Oracle Corporation (ORCL) announced its new Life Sciences AI Data Platform today, designed to accelerate pharma R&D, but shares dropped 4.08% to $165.75 as the...
🔴 Oracle is trading 3.6% down today on Morgan Stanley EPS concerns
ORCL is trading -3.55% lower at $166.66 after a Morgan Stanley note flagged the GPU-as-a-Service buildout as an EPS pressure point, potentially pushing...
Oracle Launches AI-Powered Data Platform for the Life Sciences Industry
Oracle launched the Life Sciences AI Data Platform. The solution accelerates research, development, clinical trials, and commercialization for pharmaceutical...